concord medical services - CCM

CCM

Close Chg Chg %
4.17 0.16 3.84%

Open Market

4.33

+0.16 (3.84%)

Volume: 2.03K

Last Updated:

Sep 9, 2026, 10:55 AM EDT

Company Overview: concord medical services - CCM

CCM Key Data

Open

$4.29

Day Range

4.25 - 4.33

52 Week Range

3.18 - 6.96

Market Cap

$13.18M

Shares Outstanding

2.82M

Public Float

2.38M

Beta

-0.91

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

N/A

Yield

0.00%

Dividend

$0.98

EX-DIVIDEND DATE

Dec 23, 2015

SHORT INTEREST

N/A

AVERAGE VOLUME

107.38K

 

CCM Performance

1 Week
 
-7.05%
 
1 Month
 
-3.97%
 
3 Months
 
-1.30%
 
1 Year
 
-23.82%
 
5 Years
 
-85.45%
 

CCM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About concord medical services - CCM

Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. It operates through Network Business and Hospital Business segments. It provides radiotherapy and diagnostic equipment leasing services to hospitals, and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

CCM At a Glance

Concord Medical Services Holdings Ltd.
East Zone, Hanwei Plaza
Beijing, Beijing 100020
Phone 86-10-59036688 Revenue 64.06M
Industry Medical/Nursing Services Net Income -12,911,131.75
Sector Health Services 2025 Sales Growth 20.079%
Fiscal Year-end 12 / 2026 Employees 610
View SEC Filings

CCM Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.263
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -84.588
Enterprise Value to Sales 16.546
Total Debt to Enterprise Value 0.491

CCM Efficiency

Revenue/Employee 105,021.186
Income Per Employee -21,165.79
Receivables Turnover 10.163
Total Asset Turnover 0.069

CCM Liquidity

Current Ratio 0.482
Quick Ratio 0.458
Cash Ratio 0.153

CCM Profitability

Gross Margin 5.607
Operating Margin -51.971
Pretax Margin -83.907
Net Margin -20.154
Return on Assets -1.382
Return on Equity N/A
Return on Total Capital -5.89
Return on Invested Capital -17.077

CCM Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 237.289
Total Debt to Total Assets 55.259
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 170.509
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Concord Medical Services - CCM

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
70.11M 75.85M 53.35M 64.06M
Sales Growth
-6.89% +8.19% -29.66% +20.08%
Cost of Goods Sold (COGS) incl D&A
92.74M 86.66M 64.35M 60.47M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
19.72M 18.13M 18.17M 20.76M
Depreciation
14.60M 12.95M 13.12M 15.74M
Amortization of Intangibles
5.12M 5.18M 5.05M 5.03M
COGS Growth
+10.25% -6.55% -25.75% -6.03%
Gross Income
(22.63M) (10.81M) (11.00M) 3.59M
Gross Income Growth
-156.56% +52.23% -1.73% +132.65%
Gross Profit Margin
-32.28% -14.26% -20.62% +5.61%
2022 2023 2024 2025 5-year trend
SG&A Expense
55.34M 54.53M 62.94M 36.89M
Research & Development
- - - -
-
Other SG&A
55.34M 54.53M 62.94M 36.89M
SGA Growth
-11.09% -1.45% +15.42% -41.40%
Other Operating Expense
- - - -
-
Unusual Expense
(150.73K) (734.93K) (1.04M) 3.08M
EBIT after Unusual Expense
(77.82M) (64.61M) (72.91M) (36.38M)
Non Operating Income/Expense
(31.65M) 6.64M 4.95M 3.81M
Non-Operating Interest Income
1.49M 1.53M 1.94M 1.35M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
17.87M 23.38M 26.85M 21.19M
Interest Expense Growth
+56.22% +30.82% +14.81% -21.06%
Gross Interest Expense
26.86M 31.61M 34.67M 28.30M
Interest Capitalized
8.98M 8.22M 7.83M 7.11M
Pretax Income
(127.35M) (81.35M) (94.80M) (53.75M)
Pretax Income Growth
-50.04% +36.12% -16.53% +43.30%
Pretax Margin
-181.65% -107.25% -177.70% -83.91%
Income Tax
(10.53M) (3.47M) (2.43M) 843.58K
Income Tax - Current - Domestic
(1.30M) (989.97K) (315.28K) 1.96M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(9.23M) (2.48M) (2.12M) (1.11M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(114.20M) (74.95M) (90.61M) (52.78M)
Minority Interest Expense
(41.48M) (32.94M) (47.78M) (39.87M)
Net Income
(72.72M) (42.01M) (42.83M) (12.91M)
Net Income Growth
-72.78% +42.23% -1.95% +69.86%
Net Margin Growth
-103.72% -55.39% -80.28% -20.15%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(72.72M) (42.01M) (42.83M) (12.91M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(72.72M) (42.01M) (42.83M) (12.91M)
EPS (Basic)
-16.6461 -9.6172 -9.8045 -2.9555
EPS (Basic) Growth
+42.85% +42.23% -1.95% +69.86%
Basic Shares Outstanding
4.37M 4.37M 4.37M 4.37M
EPS (Diluted)
-16.6461 -9.6172 -9.8045 -2.9555
EPS (Diluted) Growth
+42.85% +42.23% -1.95% +69.86%
Diluted Shares Outstanding
4.37M 4.37M 4.37M 4.37M
EBITDA
(58.25M) (47.22M) (55.78M) (12.53M)
EBITDA Growth
-6.05% +18.94% -18.13% +77.53%
EBITDA Margin
-83.09% -62.25% -104.54% -19.56%

Concord Medical Services in the News